Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Harpoon Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −2 vs. Q1 2023
- Shares held
- 16.9M
- −544.1K (−3.1%) vs. Q1 2023
- Total value
- $12.0M
- −$959.7K (−7.4%) vs. Q1 2023
- New holders
- 4
- 10 more added
- Sold out
- 6
- 11 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HARP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 41 | $175.5M |
| Q3 2023 | 32 | $7.53M |
| Q2 2023 | 44 | $12.0M |
| Q1 2023 | 46 | $12.9M |
| Q4 2022 | 49 | $13.7M |
| Q3 2022 | 52 | $21.0M |
| Q2 2022 | 63 | $43.4M |
| Q1 2022 | 79 | $128.2M |
| Q4 2021 | 84 | $196.3M |
| Q3 2021 | 93 | $203.9M |
| Q2 2021 | 85 | $357.3M |
| Q1 2021 | 88 | $562.3M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Harpoon Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 843 | $0 | 0.00% | +243+40.5% | Added |
| Hantz Financial Services, Inc. | 22 | $0 | 0.00% | 00.0% | Unchanged |
| Beaird Harris Wealth Management, LLC | 75 | $54 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 89 | $63 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 135 | $96 | 0.00% | +105+350.0% | Added |
| BNP Paribas Arbitrage, SA | 428 | $304 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 752 | $533 | 0.00% | −21,697−96.7% | Reduced |
| Wells Fargo & Company | 873 | $620 | 0.00% | +26+3.1% | Added |
| Advisor Group Holdings, Inc. | 1,070 | $759 | 0.00% | −1,028−49.0% | Reduced |
| Federated Hermes, Inc. | 1,133 | $804 | 0.00% | −1,718−60.3% | Reduced |
| JPMorgan Chase & Co | 1,363 | $968 | 0.00% | −73−5.1% | Reduced |
| Federation des caisses Desjardins du Quebec | 2,000 | $1.42K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 3,743 | $2.00K | 0.00% | +2,858+322.9% | Added |
| UBS Group AG | 3,142 | $2.23K | 0.00% | +600+23.6% | Added |
| Group One Trading, L.P. | 3,848 | $2.73K | 0.00% | +3,848 | New |
| Morgan Stanley | 5,725 | $4.07K | 0.00% | +2,001+53.7% | Added |
| Citadel Advisors LLC | 6,373 | $4.53K | 0.00% | +6,373 | New |
| HRT Financial LP | 10,894 | $7.00K | 0.00% | +10,894 | New |
| Tower Research Capital LLC (TRC) | 13,468 | $9.56K | 0.00% | +3,236+31.6% | Added |
| Jane Street Group, LLC | 16,734 | $11.9K | 0.00% | +16,734 | New |
| Synovus Financial Corp | 23,000 | $16.3K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 33,791 | $24.0K | 0.00% | +27,029+399.7% | Added |
| Northern Trust Corp | 37,663 | $26.7K | 0.00% | −15,284−28.9% | Reduced |
| Two Sigma Investments, LP | 43,144 | $30.6K | 0.00% | −13,936−24.4% | Reduced |
| Sequoia Financial Advisors, LLC | 63,955 | $45.4K | 0.00% | −36,045−36.0% | Reduced |
| Acadian Asset Management LLC | 76,710 | $53.0K | 0.00% | −36,992−32.5% | Reduced |
| State Street Corp | 85,232 | $60.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 88,000 | $62.5K | 0.00% | −12,000−12.0% | Reduced |
| Millennium Management LLC | 166,197 | $118.0K | 0.00% | −486,626−74.5% | Reduced |
| Renaissance Technologies LLC | 213,600 | $152.0K | 0.00% | +17,180+8.7% | Added |
| Geode Capital Management, LLC | 216,431 | $153.7K | 0.00% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 259,910 | $184.5K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 370,753 | $263.2K | 0.00% | −56,033−13.1% | Reduced |
| Lion Point Capital, LP | 456,514 | $324.1K | 0.24% | +287,231+169.7% | Added |
| Kennedy Capital Management, Inc. | 529,934 | $376.3K | 0.01% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 540,600 | $383.8K | 0.02% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 621,218 | $441.1K | 0.01% | 00.0% | Unchanged |
| Artal Group S.A. | 1,000,000 | $710.0K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,153,148 | $818.7K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,323,286 | $939.5K | 0.00% | 00.0% | Unchanged |
| MPM Asset Management LLC | 3,131,388 | $2.22M | 1.09% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $2.24M | 1.92% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 3,196,707 | $2.27M | 0.46% | 00.0% | Unchanged |
| IFP Advisors, Inc | 29 | – | – | 00.0% | Unchanged |
| Bailard, Inc. | 0 | $0 | 0.00% | −63,200−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −53,949−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −43,400−100.0% | Sold out |
| CM Wealth Advisors LLC | 0 | $0 | 0.00% | −50,354−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −30,042−100.0% | Sold out |
| Investors Research Corp | 0 | $0 | 0.00% | −60−100.0% | Sold out |